Source: Seeking Alpha

Natera received undisclosed amount in Post-IPO Equity Funding

Read full article »
Natera's Competitors | Natera's News | Natera's Financials

June 3, 2023

Pharmabiz

Invivoscribe, Complete Genomics partner to develop and commercialize biomarker tests for oncology and cancer research

Invivoscribe, a global, vertically─integrated biotechnology company, and Complete Genomics, a pioneer... See more »

June 5, 2023

MarketScreener

Illumina releases 2022 Corporate Social Responsibility Report

(marketscreener.com) SAN DIEGO, June 5, 2023 /PRNewswire/ -- Illumina Inc. , a global leader in DNA s... See more »

June 3, 2023

Pharmabiz

Invivoscribe, Complete Genomics partner to develop and commercialize biomarker tests for oncology and cancer research

Invivoscribe, a global, vertically─integrated biotechnology company, and Complete Genomics, a pioneer... See more »

June 5, 2023

MarketScreener

Illumina releases 2022 Corporate Social Responsibility Report

(marketscreener.com) SAN DIEGO, June 5, 2023 /PRNewswire/ -- Illumina Inc. , a global leader in DNA s... See more »
Stay up-to-date with the latest news on Natera
Annual Revenue
$867.8M
Employees
3,020
Steve Chapman's photo - CEO of Natera

CEO

Steve Chapman

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Natera